CRIS Current Research Information System

BARBARA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.889
NA - Nord America 1.648
EU - Europa 777
SA - Sud America 193
Continente sconosciuto - Info sul continente non disponibili 112
AF - Africa 78
Totale 4.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.594
SG - Singapore 619
VN - Vietnam 432
CN - Cina 384
HK - Hong Kong 212
BR - Brasile 155
SE - Svezia 139
IT - Italia 108
DE - Germania 97
NL - Olanda 95
RU - Federazione Russa 64
IE - Irlanda 57
GB - Regno Unito 54
FR - Francia 49
JP - Giappone 43
IN - India 42
KR - Corea 39
BG - Bulgaria 38
CA - Canada 30
CI - Costa d'Avorio 23
SC - Seychelles 23
AR - Argentina 21
FI - Finlandia 19
PH - Filippine 19
MX - Messico 16
CH - Svizzera 14
BD - Bangladesh 13
ID - Indonesia 12
UA - Ucraina 12
TG - Togo 11
IQ - Iraq 10
JO - Giordania 10
ZA - Sudafrica 10
TH - Thailandia 9
AT - Austria 8
ES - Italia 7
IR - Iran 7
PK - Pakistan 7
PL - Polonia 7
BH - Bahrain 6
TR - Turchia 6
TW - Taiwan 6
EC - Ecuador 5
CO - Colombia 4
PY - Paraguay 4
CL - Cile 3
UZ - Uzbekistan 3
BE - Belgio 2
ET - Etiopia 2
KE - Kenya 2
LT - Lituania 2
NG - Nigeria 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
BF - Burkina Faso 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
MU - Mauritius 1
MY - Malesia 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 4.585
Salva come PNG Salva come JPEG
Città #
Singapore 353
San Jose 244
Santa Clara 226
Hong Kong 201
Ashburn 150
Ho Chi Minh City 117
Chandler 114
Hanoi 97
Boardman 89
Beijing 84
Dublin 57
Princeton 48
Los Angeles 43
Southend 38
Sofia 34
Hefei 29
Tokyo 29
Seoul 28
Lauterbourg 26
New York 26
São Paulo 26
Abidjan 23
Berlin 22
Buffalo 19
Helsinki 18
Council Bluffs 16
Redondo Beach 16
Bologna 15
Chicago 15
Dallas 15
Guangzhou 15
Milan 15
Bern 14
Da Nang 14
Frankfurt am Main 13
Haiphong 13
Falkenstein 12
Houston 11
Lomé 11
Shanghai 11
Amman 10
Columbus 10
Montreal 10
Amsterdam 9
Mexico City 9
Nuremberg 9
Boston 8
Hangzhou 8
Mumbai 8
Salt Lake City 8
Yubileyny 8
Turin 7
Warsaw 7
Bengaluru 6
Bowie 6
Denver 6
Fairfield 6
Kyiv 6
Long Xuyen 6
Manila 6
Phoenix 6
Rome 6
Washington 6
Bangkok 5
Belo Horizonte 5
Biên Hòa 5
Campinas 5
Fuzhou 5
Hải Dương 5
London 5
Manama 5
Manaus 5
Quận Bình Thạnh 5
Reggio Emilia 5
San Francisco 5
Shenzhen 5
Xi'an 5
Chennai 4
Hưng Yên 4
Kunming 4
Munich 4
Olalla 4
Orem 4
Ottawa 4
Rio de Janeiro 4
Salvador 4
Shijiazhuang 4
Taiyuan 4
The Dalles 4
Thái Nguyên 4
Tianjin 4
Tân Tiến 4
Vũng Tàu 4
Wuhan 4
Brooklyn 3
Bến Tre 3
Cambridge 3
Can Tho 3
Cape Town 3
Chengdu 3
Totale 2.674
Salva come PNG Salva come JPEG
Nome #
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 283
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 263
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 122
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 110
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 109
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 109
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 108
Interleukin 1 in ulcerative colitis 108
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 106
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 104
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 103
Role of rectal formulations: Enemas 101
Cost-effectiveness analysis of the preparation of colonoscopy. Comparison between a PEG-electrolyte solution and a standard preparation 99
Macrophage subpopulations in pouchitis 99
Bronchopulmonary involvement in ulcerative colitis 97
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 96
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 96
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 93
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 91
Pentasa in maintenance treatment of ulcerative colitis 89
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 89
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 88
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 87
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration 86
Rifaximin suspension for the eradication of helicobacter pylori 78
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 72
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 63
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 63
Rifaximin suspension for the eradication of helicobacter pylori 61
Familial adenomatous polyposis and inflammatory bowel disease associated in two kindreds 61
Effects of Dietary Fat on Postprandial Gastrointestinal Motility Are Inhibited by a Cholecystokinin Type A Receptor Antagonist 59
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 59
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 56
The susceptibility of helicobacter pylori to the rifamycin, rifaximin 51
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 50
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 48
Serological response to Helicobacter pylori in gastric and non-gastric cancer 47
The susceptibility of helicobacter pylori to the rifamycin, rifaximin 45
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 45
Serological response to Helicobacter pylori in gastric and non-gastric cancer 44
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 44
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 44
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 42
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 41
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 41
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 40
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 38
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 37
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 35
Lactose Malabsorption in Adult Patients with Crohn's Disease 32
Biliary surgery without the surgeon! 31
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 30
Peptic ulcer disease and Helicobacter pylori infection 30
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 29
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 29
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 29
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 29
Peptic ulcer disease and Helicobacter pylori infection 29
Optimal nutritional indexes in gastroenterology 28
Source of Helicobacter pylori Infection 27
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 24
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 23
Helicobacter pylori: its role in gastric disease 22
Helibacter pylori and gastroduodenal disease 20
Treatment of symptom-free Helicobacter pylori-positive subjects 20
Prevalence of Helicobacter pylori in military barracks 19
Helicobacter pylori and other spiral organisms in gastroduodenal disease 19
Helicobacter pylori: its role in gastric disease 19
Helicobacter pylori and acid-related diseases of the stomach: mechanisms of pathogenesis 18
Helicobacter pylori and acid-related diseases of the stomach: mechanisms of pathogenesis 18
Helicobacter pylori and other spiral organisms in gastroduodenal disease 18
Pathogenic mechanisms of acid-related diseases: Helicobacter and other spiral organisms 17
Biliary surgery without the surgeon! 17
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors 17
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors 17
Screening for Helicobacter pylori 16
Helibacter pylori and gastroduodenal disease 15
Prevalence of Helicobacter pylori in military barracks 14
Source of Helicobacter pylori Infection 13
Treatment of symptom-free Helicobacter pylori-positive subjects 12
Pathogenic mechanisms of acid-related diseases: Helicobacter and other spiral organisms 12
Lipid, lipoprotein, and apolipoprotein assessment during an 8-wk very-low-calorie diet 4
Totale 4.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022258 0 1 1 4 2 1 1 2 81 33 100 32
2022/2023525 48 76 51 28 28 37 17 39 99 19 32 51
2023/2024270 73 33 23 24 21 49 6 22 3 13 3 0
2024/20251.097 41 81 63 59 322 50 89 37 10 109 22 214
2025/20262.393 134 181 247 168 248 100 167 206 551 223 72 96
2026/2027145 85 60 0 0 0 0 0 0 0 0 0 0
Totale 4.697